- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04679025
Quality Gaps in Screening and Monitoring for Postoperative Hyperglycemia in a Canadian Hospital
Quality Gaps in Screening and Monitoring for Postoperative Hyperglycemia in a Canadian Hospital: A Cross-sectional, Exploratory Study
Patients with and without diabetes who have postoperative hyperglycemia have worse outcomes than patients with in-target blood sugars. Previous quality improvement work suggests numerous barriers and clinical inertia may contribute to quality gaps in glycemic management for surgical patients. Using a framework for perioperative glycemic management, we sought to measure quality gaps in perioperative glycemic care.
This cross-sectional study used administrative data to measure the proportion of surgical patients with and without known diabetes who underwent preoperative hemoglobin A1c measurement, postoperative point-of-care testing for glucose (POCT), had hyperglycemia, and received basal bolus insulin regimens for treatment. We performed an exploratory analysis comparing length of stay (LOS) in patients with and without diabetes who had and did not have postoperative hyperglycemia.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4T9
- Foothills Medical Centre
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Underwent inpatient surgical procedure at the Foothills Medical Centre between Apr 1 2019 and March 31 2020
- Stayed in hospital for more than 24-hours after surgery
Exclusion Criteria:
- Younger than 18 years of age
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Diabetes with postoperative hyperglycemia
Patients with known diabetes (Discharge Abstract Database or hemoglobin A1c > 6.5%) who had postoperative hyperglycemia (point of care test > 10.0 mmol/L).
|
Postoperative hyperglycemia (blood or capillary glucose > 10.0 mmol/L) within 72 hours of a surgical procedure
|
Diabetes without postoperative hyperglycemia
Patients with known diabetes (Discharge Abstract Database or hemoglobin A1c > 6.5%) who did not have postoperative hyperglycemia (point of care test > 10.0 mmol/L).
|
|
No diabetes with postoperative hyperglycemia
Patients without known diabetes (Discharge Abstract Database or hemoglobin A1c > 6.5%) who had postoperative hyperglycemia (point of care test > 10.0 mmol/L).
|
Postoperative hyperglycemia (blood or capillary glucose > 10.0 mmol/L) within 72 hours of a surgical procedure
|
No diabetes and no postoperative hyperglycemia
Patients without known diabetes (Discharge Abstract Database or hemoglobin A1c > 6.5%) who did not have postoperative hyperglycemia (point of care test > 10.0 mmol/L).
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Number of point of care blood glucose measurements in 24-hours after surgery
Tidsramme: 24-hours post surgery
|
24-hours post surgery
|
|
Proportion of patients who have hyperglycemia
Tidsramme: 24-hours after surgery
|
blood or capillary glucose > 10 mmol/L
|
24-hours after surgery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Proportion of patients who have moderate hyperglycemia
Tidsramme: 24-hours after surgery
|
blood or capillary glucose 14.0-17.9
mmol/L
|
24-hours after surgery
|
Proportion of patients who have severe hyperglycemia
Tidsramme: 24-hours after surgery
|
blood or capillary glucose > 18.0 mmol/L
|
24-hours after surgery
|
Hospital Length of stay
Tidsramme: Until study completion (up to one year from surgical procedure)
|
Hospital length of stay (days)
|
Until study completion (up to one year from surgical procedure)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- HREBA.CC-19-0157
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Exposure - postoperative hyperglycemia
-
George Washington UniversityHar ikke rekruttert ennå
-
UConn HealthFullførtKarpaltunellsyndromForente stater
-
Hacettepe UniversityFullførtSkoliose idiopatisk | Skoliose; UngdomstidenTyrkia
-
Cancer Institute and Hospital, Chinese Academy...Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer...UkjentNeoplasma i spiserøret | Esophageal Cancer TNM Staging Primærtumor (T) T3 | Esophageal Cancer TNM Staging Primærtumor (T) T2 | Esophageal Cancer TNM Staging Regionale lymfeknuter (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0Kina
-
University of Cape TownBill and Melinda Gates FoundationFullført
-
Cihangir AkyolFullførtDepresjon | Livskvalitet | Angst | Stomi
-
Cancer Institute and Hospital, Chinese Academy...FullførtThoracale neoplasmer | Ikke-småcellet lungekreftKina
-
Oslo University HospitalUkjentHornhinnedystrofier, arvelig | Fuchs' endoteldystrofi | Korneatransplantasjon | Descemet stripping automatisk endotelial keratoplastikkNorge
-
Yale UniversityBoston Scientific CorporationRekrutteringUrinbelastningsinkontinensForente stater
-
Kyle Schweser MDRekruttering